Previous Page  19 / 37 Next Page
Information
Show Menu
Previous Page 19 / 37 Next Page
Page Background

Page 73

Notes:

conferenceseries

.com

Volume 9, Issue 9 (Suppl)

J Cancer Sci Ther, an open access journal

ISSN: 1948-5956

World Cancer 2017

October 19-21, 2017

25

th

WORLD CANCER CONFERENCE

October 19-21, 2017 | Rome, Italy

Anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal

squamous cell carcinoma cells

Fatemeh Alibeiki

Ardabil University of Medical Sciences, Iran

C

urcumin and its chalcone derivatives inhibit the growth of human cancer cells. It is reported that replacement of two OH

groups in curcumin with less polar groups like methoxy increases its antiproliferative activity. In this study, we explored

benzylidene cyclohexanone derivatives with non-polar groups, to see if they possess increased anti-cancer activity. Novel 2,6-

bis benzylidene cyclohexanone analogues of curcumin were synthesized, and their inhibitory effects on gastric adenocarcinoma

(AGS) and esophageal squamous cell carcinoma (KYSE30) cancer cells were studied using an MTT assay. Cell apoptosis was

detected by EB/AO staining, and cell cycle was analyzed by flow cytometry. Real-time PCR was performed for gene expression

analysis. All synthesized analogues were cytotoxic toward gastric and esophageal cancer cells and showed lower IC50 values

than curcumin. Treatment with 2,6-Bis-(3-methoxy-4-propoxy-benzylidene)-cyclohexanone (BM2) was 17 times more toxic

than curcumin after 48 h incubation. All novel compounds were more effective than curcumin in apoptosis induction and cell

cycle arrest at G1 phase. These results suggest that less polar analogues of curcumin have potent cytotoxicity

in vitro

. However,

they need to be investigated further, especially with animal tumor models, to confirm their chemotherapeutic activity

in vivo

.

Biography

Fatemeh Alibeiki has been studying at Ardabil University of Medical Sciences, Iran. Currently, she is in her final year of education as a medical student. So far, she

has published two papers in high-profile journals. Participating in numerous conferences and workshops is one of her interests and has done so, on a regular basis

throughout the years as a student which brought her experience, extensive knowledge and so many scientific certificates. She has also associated with different

groups in her university that resulted in holding several conferences and meetings.

fatemeh1991.ma@gmail.com

Fatemeh Alibeiki, J Cancer Sci Ther 2017, 9:9(Suppl)

DOI: 10.4172/1948-5956-C1-112